Document Detail

Covalent linkage of N-methyl-6-oxyquinolinium betaine to trehalose.
MedLine Citation:
PMID:  22078244     Owner:  NLM     Status:  Publisher    
The common route to link quinolinium and pyridinium fluorophores to biomolecules via bromoacetic acid has failed in labeling the disaccharide trehalose with N-methyl-6-oxyquinolinium betaine: the unexpected, extremely high instability of the N-carboxymethyl ester was overcome by direct N-alkylation of the quinoline derivative with trehalose triflate.
Falko Berndt; Mohsen Sajadi; Nikolaus P Ernsting; Rainer Mahrwald
Related Documents :
3518954 - Effects of arsenate and ergot alkaloid compounds on prostacyclin synthesis in human umb...
6097594 - Determination of leukotrienes and prostaglandins in [14c] arachidonic acid labelled hum...
824724 - Inhibition of prostaglandin biosynthesis by tolfenamic acid in vitro.
3895394 - Protection of the gastroduodenal mucosa by prostaglandins.
21112364 - The nutritive value of grasspea (lathyrus sativus) and allied species, their toxicity t...
745654 - Amino acid transport in the retina.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-19
Journal Detail:
Title:  Carbohydrate research     Volume:  -     ISSN:  1873-426X     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-11-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0043535     Medline TA:  Carbohydr Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Ltd. All rights reserved.
Department of Chemistry, Humboldt-Universität zu Berlin, Brook-Taylor-Straße 2, 12489 Berlin, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Validation of the Spence Children's Anxiety Scale's obsessive compulsive subscale in a clinical and ...
Next Document:  C1-esterase inhibitor protects against early vein graft remodeling under arterial blood pressure.